Kumquat Biosciences develops therapeutic solutions for cancer treatment.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
07/28/2021 | Series A-2 | $30MM | $xx.xx | $49.5B | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
2,905,883
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
02/05/2021 | Series A-1 | $50MM | $xx.xx | $33.73B | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
6,053,921
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
07/02/2019 | Series A | $55.92MM | $xx.xx | $9.32B | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
20,489,018
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|